These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

191 related items for PubMed ID: 19695401

  • 1. Impact of the heterozygous TPMT*1/*3C genotype on azathioprine-induced myelosuppression in kidney transplant recipients in Thailand.
    Vannaprasaht S, Angsuthum S, Avihingsanon Y, Sirivongs D, Pongskul C, Makarawate P, Praditpornsilpa K, Tassaneeyakul W, Tassaneeyakul W.
    Clin Ther; 2009 Jul; 31(7):1524-33. PubMed ID: 19695401
    [Abstract] [Full Text] [Related]

  • 2. The impact of thiopurine s-methyltransferase polymorphism on azathioprine-induced myelotoxicity in renal transplant recipients.
    Kurzawski M, Dziewanowski K, Gawrońska-Szklarz B, Domański L, Droździk M.
    Ther Drug Monit; 2005 Aug; 27(4):435-41. PubMed ID: 16044099
    [Abstract] [Full Text] [Related]

  • 3. Relationships between thiopurine S-methyltransferase polymorphism and azathioprine-related adverse drug reactions in Chinese renal transplant recipients.
    Xin HW, Xiong H, Wu XC, Li Q, Xiong L, Yu AR.
    Eur J Clin Pharmacol; 2009 Mar; 65(3):249-55. PubMed ID: 19048245
    [Abstract] [Full Text] [Related]

  • 4. TPMT but not ITPA gene polymorphism influences the risk of azathioprine intolerance in renal transplant recipients.
    Kurzawski M, Dziewanowski K, Lener A, Drozdzik M.
    Eur J Clin Pharmacol; 2009 May; 65(5):533-40. PubMed ID: 19229528
    [Abstract] [Full Text] [Related]

  • 5. Azathioprine-induced fatal myelosuppression in systemic lupus erythematosus patient carrying TPMT*3C polymorphism.
    Boonsrirat U, Angsuthum S, Vannaprasaht S, Kongpunvijit J, Hirankarn N, Tassaneeyakul W, Avihingsanon Y.
    Lupus; 2008 Feb; 17(2):132-4. PubMed ID: 18250137
    [Abstract] [Full Text] [Related]

  • 6. TPMT genotype and its clinical implication in renal transplant recipients with azathioprine treatment.
    Song DK, Zhao J, Zhang LR.
    J Clin Pharm Ther; 2006 Dec; 31(6):627-35. PubMed ID: 17176368
    [Abstract] [Full Text] [Related]

  • 7. TPMT*26 (208F-->L), a novel mutation detected in a Chinese.
    Kham SK, Soh CK, Aw DC, Yeoh AE.
    Br J Clin Pharmacol; 2009 Jul; 68(1):120-3. PubMed ID: 19660010
    [Abstract] [Full Text] [Related]

  • 8. Association of thiopurine methyltransferase status with azathioprine side effects in Chinese patients with systemic lupus erythematosus.
    Chen D, Lian F, Yuan S, Wang Y, Zhan Z, Ye Y, Qiu Q, Xu H, Liang L, Yang X.
    Clin Rheumatol; 2014 Apr; 33(4):499-503. PubMed ID: 24322830
    [Abstract] [Full Text] [Related]

  • 9. Thiopurine S-methyltransferase polymorphism in Iranian kidney transplant recipients.
    Aghdaie MH, Azarpira N, Geramizadeh B, Sagheb M, Darai M, Rahsaz M, Malekhoseini SA.
    Exp Clin Transplant; 2011 Aug; 9(4):241-6. PubMed ID: 21819368
    [Abstract] [Full Text] [Related]

  • 10. Thiopurine S-methyltransferase genotype predicts azathioprine-induced myelotoxicity in kidney transplant recipients.
    Formea CM, Myers-Huentelman H, Wu R, Crabtree J, Fujita S, Hemming A, Reed A, Howard R, Karlix JL.
    Am J Transplant; 2004 Nov; 4(11):1810-7. PubMed ID: 15476481
    [Abstract] [Full Text] [Related]

  • 11. Thiopurine S-methyltransferase polymorphisms and the relationship between the mutant alleles and the adverse effects in systemic lupus erythematosus patients taking azathioprine.
    Jun JB, Cho DY, Kang C, Bae SC.
    Clin Exp Rheumatol; 2005 Nov; 23(6):873-6. PubMed ID: 16396707
    [Abstract] [Full Text] [Related]

  • 12. Thiopurine-methyltransferase variants in inflammatory bowel disease: prevalence and toxicity in Brazilian patients.
    Carvalho AT, Esberard BC, Fróes RS, Rapozo DC, Grinman AB, Simão TA, Santos JC, Carneiro AJ, Ribeiro-Pinto LF, de Souza HS.
    World J Gastroenterol; 2014 Mar 28; 20(12):3327-34. PubMed ID: 24696613
    [Abstract] [Full Text] [Related]

  • 13. Frequency of thiopurine S-methyltransferase genetic variation in Thai children with acute leukemia.
    Hongeng S, Sasanakul W, Chuansumrit A, Pakakasama S, Chattananon A, Hathirat P.
    Med Pediatr Oncol; 2000 Oct 28; 35(4):410-4. PubMed ID: 11025471
    [Abstract] [Full Text] [Related]

  • 14. Azathioprine-induced fatal myelosuppression in a renal-transplant recipient who carried heterozygous TPMT*1/*3C.
    Tassaneeyakul W, Srimarthpirom S, Reungjui S, Chansung K, Romphruk A, Tassaneeyakul W.
    Transplantation; 2003 Jul 15; 76(1):265-6. PubMed ID: 12865824
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Thiopurine S-methyltransferase gene polymorphism is predictive of azathioprine-induced myelosuppression in heart transplant recipients.
    Sebbag L, Boucher P, Davelu P, Boissonnat P, Champsaur G, Ninet J, Dureau G, Obadia JF, Vallon JJ, Delaye J.
    Transplantation; 2000 Apr 15; 69(7):1524-7. PubMed ID: 10798786
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.